Web Analytics

Start up Profile

AlgoTx

AlgoTx France - Suresnes, Ile-de-France
START UP

1 Disclosed Funding Rounds $21,157,000
0 Participating Investments




AlgoTx develops novel solutions for complex pain. Our lead program, ATX01, targets highly prevalent Chemotherapy-Induced Peripheral Neuropathy and the orphan disease erythromelalgia.

Capital Raised

Date Round Raised Participating Investors
March, 15 ,2023 Series B $21,157,000